United States · Funded startup
Funding summaryUpdated 26 Oct 2026
$168Mraised across 5 rounds since 2013, from 5 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Source recordedSEC filing: $60M sold, first sale Oct 2025
Reported by FinSMEs
Google Ventures
Novartis
Incube Ventures
Pacific Opportunity Capital Ltd.
The Stevanato Group
VentureHealthFrom a historical funding recordSEC filing: $15M sold, first sale May 2015
From Rani Therapeutics's own website and the SEC filings it signed: 11 on the team.
On the board, as filediAndrew FarquharsonDennis AusielloMaulik Nanavaty
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Google VenturesNovartis
RA Capital Management
Invus
Samsara BioCapital
Cathay Capital
AstraZenecaPing An Capital
Shire
InCube VenturesMissing a round, or an investor who was in one? Tell us.
Rani Therapeutics's investors include Google Ventures, Novartis, RA Capital Management, Invus and Samsara BioCapital, and 15 more on record.
Rani Therapeutics has raised $168M across 5 rounds since 2013. One round did not disclose an amount, so the total is a floor.
Rani Therapeutics's most recent round was an Undisclosed round of $60M in Oct 2025.
Its most recent round, $60M in Oct 2025, is also its largest on record.
Rani Therapeutics's first round on record, in Aug 2013, was backed by Google Ventures and InCube Ventures.
Rani Therapeutics's latest named round is an Undisclosed round, in Oct 2025.
Rani Therapeutics is based in the United States.
In the same sector, and raised in the last eighteen months.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States · 
